Annual Report 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / April 4, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Today XVIVO Perfusion AB (publ) publish the Annual...
Year: 2024
New Life Solutions Addresses Florida Court Decision to Bring Major Changes to Abortion Laws
TAMPA, FL / ACCESSWIRE / April 4, 2024 / On April 1, 2024, the Florida State Supreme Court rendered two...
Otsuka Works with Verily to Launch Longitudinal Mental Health Registry to Advance Novel Research in Psychiatry
The ‘My Mental Health Journey’ registry is now enrolling U.S.-based adults experiencing symptoms of depression. The Otsuka-sponsored registry study is...
Primary Care Medical Partners Selects eClinicalWorks AI Solutions and Sunoh.ai to Save Time on Documentation and Reduce Physician Burnout
The advanced AI solutions and AI medical scribe will assist the practice in streamlining clinical documentation and enhancing patient engagementWESTBOROUGH,...
National Alliance on Mental Illness (NAMI) Launches the Schizophrenia and Psychosis Lexicon Guide: A Milestone in Mental Health Communication
WASHINGTON, DC / ACCESSWIRE / April 4, 2024 / The National Alliance on Mental Illness (NAMI), the nation's largest grassroots...
AlayaCare Named Preferred Home Care Technology Partner by Closing the Gap Healthcare
TORONTO, ON / ACCESSWIRE / April 4, 2024 / Closing the Gap Healthcare (CTG) announced today that it has signed...
Halberd’s Patented Drug, LDN+, the Subject of a Limited Clinical Trial Under an Innovative Four-Company Cooperative Research and Development (CRADA) Contract
JACKSON CENTER, PA / ACCESSWIRE / April 4, 2024 / Halberd Corporation's (OTC PINK:HALB) Patented LDN+ Drug hits an enormous...
Participants in Nigeria Vaccinated in First-Ever Phase 2 Lassa Fever Vaccine Clinical Trial, Sponsored by IAVI
The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI's single dose Lassa fever vaccine candidateKey takeaways:Participants in...
IHM Senior Living Community Becomes Licensed by the State of Michigan for Assisted Living Services
Community is now open for all levels of careMONROE, MI / ACCESSWIRE / April 4, 2024 / The IHM Senior...
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
BOULDER, CO / ACCESSWIRE / April 4, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
Potentially differentiated, multivalent candidate encodes antigens matched to all four WHO-recommended flu strainsFor influenza A strains, geometric mean titers numerically...
PLHM Expands Presence in Alberta with Acquisition of a Clinic in Fort Saskatchewan and an Additional Virtual Presence Across Canada
Calgary, Alberta--(Newsfile Corp. - April 4, 2024) - PLHM, a leading healthcare solutions provider, is pleased to announce the successful...
Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announces a strategic partnership with Navierre, an...
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO): Fiscal Year 2024 Third Quarter Highlights Completed the sale of its PICC and Midline...
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
New Indication for Treatment of Pulmonary Embolism Enhances Device Utility in Critical Medical ScenariosLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a...
Red Light Holland Partners with Professor David Nutt and Drug Science to Analyze iMicroapp Data and Promote Responsible Regulations For Psilocybin Microdosing
Toronto, Ontario--(Newsfile Corp. - April 4, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for...
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing...
Over 52 Million Myeloma Warriors Reached, Creating Ripples Across the Globe for #MyelomaACTIONMonth
2024 Myeloma Action Month Global Campaign Brings Wave of Myeloma Awareness to 36 Countries WorldwideSTUDIO CITY, Calif., April 04, 2024...
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
WARMINSTER, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive...